Instil Bio Inc TIL

Healthcare Biotechnology

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.

NDAQ:TIL - Post by User

Instil Bio Inc

Bullboard Posts

Comment by joe_trouton Aug 26, 2011 3:15pm

225 Views

Post# 18983954

RE: RE: RE: 20 million shares traded

It's funny watching people twist in the wind over pennies. All of those warrants if exercised will just put a lot more money in the treasury. GPD is set up pretty well. Pretty much free from having to go to the banker slime ball parasitic institutions with hat in hand. Not too many Jr's are in this position...along with the excellent royalty, land, and drilling results position. GPD is still an undiscovered gem...I also loaded up yesterday on top of my already loaded up position. No concerns about GPD in the slightest...unless the CEO gets killed by a bear in the Yukon. Then I might worry a little.

Bullboard Posts

Canadian artificial intelligence ETFs